Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Patients who have obstructive sleep apnea (OSA) frequently stop breathing while they sleep.
They often develop high blood pressure. We are not sure what drug is best to treat the high
blood pressure. This study will give the patients nebivolol or hydrochlorothiazide (HCTZ) for
6 weeks after 2 weeks of placebo. The blood pressure response will be evaluated by 24 hour
monitoring.